• Something wrong with this record ?

Quality assurance method for monitoring of lateral pencil beam positions in scanned carbon-ion radiotherapy using tracking of secondary ions

R. Félix-Bautista, L. Ghesquière-Diérickx, L. Marek, C. Granja, P. Soukup, D. Turecek, L. Kelleter, S. Brons, M. Ellerbrock, O. Jäkel, T. Gehrke, M. Martišíková

. 2021 ; 48 (8) : 4411-4424. [pub] 20210628

Language English Country United States

Document type Journal Article

PURPOSE: Ion beam radiotherapy offers enhances dose conformity to the tumor volume while better sparing healthy tissue compared to conventional photon radiotherapy. However, the increased dose gradient also makes it more sensitive to uncertainties. While the most important uncertainty source is the patient itself, the beam delivery is also subject to uncertainties. Most of the proton therapy centers used cyclotrons, which deliver typically a stable beam over time, allowing a continuous extraction of the beam. Carbon-ion beam radiotherapy (CIRT) in contrast uses synchrotrons and requires a larger and energy-dependent extrapolation of the nozzle-measured positions to obtain the lateral beam positions in the isocenter, since the nozzle-to-isocenter distance is larger than for cyclotrons. Hence, the control of lateral pencil beam positions at isocenter in CIRT is more sensitive to uncertainties than in proton radiotherapy. Therefore, an independent monitoring of the actual lateral positions close to the isocenter would be very valuable and provide additional information. However, techniques capable to do so are scarce, and they are limited in precision, accuracy and effectivity. METHODS: The detection of secondary ions (charged nuclear fragments) has previously been exploited for the Bragg peak position of C-ion beams. In our previous work, we investigated for the first time the feasibility of lateral position monitoring of pencil beams in CIRT. However, the reported precision and accuracy were not sufficient for a potential implementation into clinical practice. In this work, it is shown how the performance of the method is improved to the point of clinical relevance. To minimize the observed uncertainties, a mini-tracker based on hybrid silicon pixel detectors was repositioned downstream of an anthropomorphic head phantom. However, the secondary-ion fluence rate in the mini-tracker rises up to 1.5 × 105 ions/s/cm2 , causing strong pile-up of secondary-ion signals. To solve this problem, we performed hardware changes, optimized the detector settings, adjusted the setup geometry and developed new algorithms to resolve ambiguities in the track reconstruction. The performance of the method was studied on two treatment plans delivered with a realistic dose of 3 Gy (RBE) and averaged dose rate of 0.27 Gy/s at the Heidelberg Ion-Beam Therapy Center (HIT) in Germany. The measured lateral positions were compared to reference beam positions obtained either from the beam nozzle or from a multi-wire proportional chamber positioned at the room isocenter. RESULTS: The presented method is capable to simultaneously monitor both lateral pencil beam coordinates over the entire tumor volume during the treatment delivery, using only a 2-cm2 mini-tracker. The effectivity (defined as the fraction of analyzed pencil beams) was 100%. The reached precision of (0.6 to 1.5) mm and accuracy of (0.5 to 1.2) mm are in line with the clinically accepted uncertainty for QA measurements of the lateral pencil beam positions. CONCLUSIONS: It was demonstrated that the performance of the method for a non-invasive lateral position monitoring of pencil beams is sufficient for a potential clinical implementation. The next step is to evaluate the method clinically in a group of patients in a future observational clinical study.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21025249
003      
CZ-PrNML
005      
20211026134005.0
007      
ta
008      
211013s2021 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1002/mp.15018 $2 doi
035    __
$a (PubMed)34061994
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Félix-Bautista, Renato $u Department of Medical Physics in Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, 69120, Germany $u Faculty of Physics and Astronomy, Heidelberg University, Heidelberg, 69120, Germany $u Heidelberg Institute for Radiation Oncology (HIRO), National Center for Research in Radiation Oncology (NCRO), Heidelberg, 69120, Germany
245    10
$a Quality assurance method for monitoring of lateral pencil beam positions in scanned carbon-ion radiotherapy using tracking of secondary ions / $c R. Félix-Bautista, L. Ghesquière-Diérickx, L. Marek, C. Granja, P. Soukup, D. Turecek, L. Kelleter, S. Brons, M. Ellerbrock, O. Jäkel, T. Gehrke, M. Martišíková
520    9_
$a PURPOSE: Ion beam radiotherapy offers enhances dose conformity to the tumor volume while better sparing healthy tissue compared to conventional photon radiotherapy. However, the increased dose gradient also makes it more sensitive to uncertainties. While the most important uncertainty source is the patient itself, the beam delivery is also subject to uncertainties. Most of the proton therapy centers used cyclotrons, which deliver typically a stable beam over time, allowing a continuous extraction of the beam. Carbon-ion beam radiotherapy (CIRT) in contrast uses synchrotrons and requires a larger and energy-dependent extrapolation of the nozzle-measured positions to obtain the lateral beam positions in the isocenter, since the nozzle-to-isocenter distance is larger than for cyclotrons. Hence, the control of lateral pencil beam positions at isocenter in CIRT is more sensitive to uncertainties than in proton radiotherapy. Therefore, an independent monitoring of the actual lateral positions close to the isocenter would be very valuable and provide additional information. However, techniques capable to do so are scarce, and they are limited in precision, accuracy and effectivity. METHODS: The detection of secondary ions (charged nuclear fragments) has previously been exploited for the Bragg peak position of C-ion beams. In our previous work, we investigated for the first time the feasibility of lateral position monitoring of pencil beams in CIRT. However, the reported precision and accuracy were not sufficient for a potential implementation into clinical practice. In this work, it is shown how the performance of the method is improved to the point of clinical relevance. To minimize the observed uncertainties, a mini-tracker based on hybrid silicon pixel detectors was repositioned downstream of an anthropomorphic head phantom. However, the secondary-ion fluence rate in the mini-tracker rises up to 1.5 × 105 ions/s/cm2 , causing strong pile-up of secondary-ion signals. To solve this problem, we performed hardware changes, optimized the detector settings, adjusted the setup geometry and developed new algorithms to resolve ambiguities in the track reconstruction. The performance of the method was studied on two treatment plans delivered with a realistic dose of 3 Gy (RBE) and averaged dose rate of 0.27 Gy/s at the Heidelberg Ion-Beam Therapy Center (HIT) in Germany. The measured lateral positions were compared to reference beam positions obtained either from the beam nozzle or from a multi-wire proportional chamber positioned at the room isocenter. RESULTS: The presented method is capable to simultaneously monitor both lateral pencil beam coordinates over the entire tumor volume during the treatment delivery, using only a 2-cm2 mini-tracker. The effectivity (defined as the fraction of analyzed pencil beams) was 100%. The reached precision of (0.6 to 1.5) mm and accuracy of (0.5 to 1.2) mm are in line with the clinically accepted uncertainty for QA measurements of the lateral pencil beam positions. CONCLUSIONS: It was demonstrated that the performance of the method for a non-invasive lateral position monitoring of pencil beams is sufficient for a potential clinical implementation. The next step is to evaluate the method clinically in a group of patients in a future observational clinical study.
650    _2
$a uhlík $7 D002244
650    12
$a radioterapie těžkými ionty $7 D063193
650    _2
$a lidé $7 D006801
650    _2
$a ionty $7 D007477
650    _2
$a metoda Monte Carlo $7 D009010
650    12
$a protonová terapie $7 D061766
650    _2
$a celková dávka radioterapie $7 D011879
650    _2
$a plánování radioterapie pomocí počítače $7 D011880
655    _2
$a časopisecké články $7 D016428
700    1_
$a Ghesquière-Diérickx, Laura $u Department of Medical Physics in Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, 69120, Germany $u Heidelberg Institute for Radiation Oncology (HIRO), National Center for Research in Radiation Oncology (NCRO), Heidelberg, 69120, Germany $u Medical Faculty, Heidelberg University, Heidelberg, 69120, Germany
700    1_
$a Marek, Lukáš $u Department of Research and Development, ADVACAM s.r.o., Prague, 17000, Czech Republic
700    1_
$a Granja, Carlos $u Department of Research and Development, ADVACAM s.r.o., Prague, 17000, Czech Republic
700    1_
$a Soukup, Pavel $u Department of Research and Development, ADVACAM s.r.o., Prague, 17000, Czech Republic
700    1_
$a Turecek, Daniel $u Department of Research and Development, ADVACAM s.r.o., Prague, 17000, Czech Republic
700    1_
$a Kelleter, Laurent $u Department of Medical Physics in Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, 69120, Germany $u Heidelberg Institute for Radiation Oncology (HIRO), National Center for Research in Radiation Oncology (NCRO), Heidelberg, 69120, Germany
700    1_
$a Brons, Stephan $u Heidelberg Ion-Beam Therapy Center (HIT), Heidelberg, 69120, Germany
700    1_
$a Ellerbrock, Malte $u Heidelberg Ion-Beam Therapy Center (HIT), Heidelberg, 69120, Germany
700    1_
$a Jäkel, Oliver $u Department of Medical Physics in Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, 69120, Germany $u Heidelberg Institute for Radiation Oncology (HIRO), National Center for Research in Radiation Oncology (NCRO), Heidelberg, 69120, Germany $u Heidelberg Ion-Beam Therapy Center (HIT), Heidelberg, 69120, Germany
700    1_
$a Gehrke, Tim $u Department of Medical Physics in Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, 69120, Germany $u Heidelberg Institute for Radiation Oncology (HIRO), National Center for Research in Radiation Oncology (NCRO), Heidelberg, 69120, Germany $u Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, 69120, Germany
700    1_
$a Martišíková, Mária $u Department of Medical Physics in Radiation Oncology, German Cancer Research Center (DKFZ), Heidelberg, 69120, Germany $u Heidelberg Institute for Radiation Oncology (HIRO), National Center for Research in Radiation Oncology (NCRO), Heidelberg, 69120, Germany
773    0_
$w MED00003245 $t Medical physics $x 2473-4209 $g Roč. 48, č. 8 (2021), s. 4411-4424
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34061994 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20211013 $b ABA008
991    __
$a 20211026134011 $b ABA008
999    __
$a ok $b bmc $g 1714347 $s 1145756
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 48 $c 8 $d 4411-4424 $e 20210628 $i 2473-4209 $m Medical physics $n Med Phys $x MED00003245
LZP    __
$a Pubmed-20211013

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...